Leverone Jason A. 4
4 · OnKure Therapeutics, Inc. · Filed Mar 24, 2026
Research Summary
AI-generated summary of this filing
OnKure (OKUR) CFO Jason Leverone Sells 301 Shares
What Happened
Jason A. Leverone, Chief Financial Officer of OnKure Therapeutics (OKUR), had 301 shares disposed of on 2026-03-23 in an open-market/private sale. The shares were sold at a weighted average price of $4.16 per share for a total of approximately $1,251. This sale was an automatic disposition to satisfy tax withholding tied to the vesting of restricted stock units (RSUs), not an independent decision to sell shares for investment purposes.
Key Details
- Transaction date: 2026-03-23; filing date: 2026-03-24 (appears timely).
- Shares sold: 301; weighted average sale price: $4.16; total proceeds: ~$1,251.
- Footnote highlights:
- F1: Shares were automatically sold to cover tax withholding on RSU vesting (Issuer’s 2023 RSU Plan).
- F2: Sale executed in multiple trades at prices between $3.995 and $4.235; $4.16 is the weighted average.
- F3: The underlying securities were RSUs (each RSU converts to one share upon vesting).
- Shares owned after the transaction: Not specified in the provided filing.
Context
This was a tax-withholding sale tied to RSU vesting (transaction code typically F), which is a routine administrative event and not necessarily a signal of the CFO’s view on company prospects. For derivative-related activity: RSUs vested and a portion of shares were sold automatically to cover taxes rather than a market-driven sale by the insider.
Insider Transaction Report
- Sale
Class A Common Stock
[F1][F2][F3]2026-03-23$4.16/sh−301$1,251→ 16,000 total
Footnotes (3)
- [F1]These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $3.995 to $4.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.